Avid Bioservices Inc (CDMO)

[freethemice]

This new phase I trial for rectal adenocarcinoma resembles a phase II trial which also
used capecitabine and radiation, but Avastin was added. Note that capecitabine is a
prodrug which converts into 5-FU internally and is made by Roche and sold as Xeloda.
This paper about the trial is freely available. It gives some background on the treatment
of LARC (locally advanced rectal carcinoma).
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3179720/?tool=pubmed